NorthX Biologics is a Swedish CDMO specialising in biologics, including advanced therapeutics like mRNA, viral vectors, and cell therapies.

NorthX Biologics supports clients in developing and manufacturing biologics from pre-clinical stages to commercialisation. With facilities in Matfors and Stockholm, Sweden, the company offers cutting-edge expertise in advanced therapeutic modalities. Recognised as an Innovation Hub, NorthX focuses on process development, rapid scale-up, and regulatory compliance. Their tailored solutions enable life-changing therapies through reliable and flexible services.

Key Products and Services:

• Process Development: End-to-end support for biologics manufacturing.
• Analytics: Comprehensive testing services for RNA/DNA, proteins, and vaccines.
• Recombinant Proteins: Gene-to-protein solutions using multiple expression systems.
• Viral Vectors: Production of GMP and non-GMP AAV, lentivirus, and other vectors.
• Plasmid DNA: For DNA vaccines and gene therapies.
• mRNA: State-of-the-art mRNA production services.
• Cell Therapy: Development and production for various cell types.
• Aseptic Fill/Finish: High-quality pharmaceutical packaging solutions.

Final Paragraph:
With a commitment to innovation and collaboration, NorthX Biologics positions itself as a strategic partner in advancing biologics programs. Their client-centric approach, advanced technologies, and experienced team ensure efficient and high-quality outcomes, helping to accelerate the journey from discovery to clinical success. Visit NorthX Biologics for more information.